Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 587-594

  Klarenbach, Scott ^a,b,c   Tonelli, Marcello ^a,c   Pauly, Robert ^a   Walsh, Michael ^d   Culleton, Bruce ^e   So, Helen ^a   Hemmelgarn, Brenda ^c,f   Manns, Braden ^c,f  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c Alberta Kidney Disease Network   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e BAXTER HEALTHCARE CORPORATION   (United States)

^f LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; IRON;

ADULT; ARTICLE; CANADA; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FEMALE; FREQUENT HOME NOCTURNAL HEMODIALYSIS; HEALTH CARE COST; HOME DIALYSIS; HOSPITALIZATION COST; HUMAN; MALE; MIDDLE AGED; PATIENT INFORMATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; SENSITIVITY ANALYSIS; UNITED STATES;

COST-BENEFIT ANALYSIS; FEMALE; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84896840979     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040360     Document Type: Article

References (32)

1. Canadian Institute for Health Information: Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, Ottawa, ON, Canada, Canadian Institute for Health Information, 2011
2. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricularmass and quality of life: A randomized controlled trial. JAMA 298: 1291-1299, 2007 (Pubitemid 47443343)
3. Walsh M, Culleton B, Tonelli M, Manns B: A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67: 1500-1508, 2005 (Pubitemid 40463127)
4. Manns BJ, Walsh MW, Culleton BF, Hemmelgarn B, Tonelli M, Schorr M, Klarenbach S: Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int 75: 542-549, 2009
5. RoccoMV, Lockridge RS Jr., Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B,Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S; Frequent Hemo-dialysis Network (FHN) Trial Group: The effects of frequent nocturnal home hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80: 1080-1091, 2011
6. Komenda P, Levin A, Manns B: The economics of home nocturnal hemodialysis: How should we cost the benefits? Clin Nephrol 68: 151-158, 2007 (Pubitemid 47377337)
7. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 64: 1004-1011, 2003 (Pubitemid 37013836)
8. McFarlane PA, Pierratos A, Redelmeier DA: Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 62: 2216-2222, 2002 (Pubitemid 35366178)
9. Kroeker A, Clark WF, Heidenheim AP, Kuenzig L, Leitch R, Meyette M, Muirhead N, Ryan H, Welch R, White S, Lindsay RM: An operating cost comparison between conventional and home quotidian hemodialysis. AmJ Kidney Dis 42[Suppl]: 49-55, 2003
10. Mohr PE,Neumann PJ, Franco SJ,Marainen J, Lockridge R, TingG: The case for daily dialysis: Its impact on costs and quality of life. AmJ Kidney Dis 37: 777-789, 2001 (Pubitemid 32268039)
11. Laupacis A: Economic evaluations in the canadian common drug review. Pharmacoeconomics 24: 1157-1162, 2006
12. Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ: Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada. JAMA 302: 1437-1443, 2009
13. Rocchi A, Menon D, Verma S, Miller E: The role of economic evidence in Canadian oncology reimbursement decision-making: To lambda and beyond. Value Health 11: 771-783, 2008 (Pubitemid 352032812)
14. Pauly RP, Maximova K, Coppens J, Asad RA, Pierratos A, Komenda P, Copland M, Nesrallah GE, Levin A, Chery A, Chan CT; CAN-SLEEP CollaborativeGroup: Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol 5: 1815-1820, 2010
15. Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO; FREEDOM Study Group: Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol 6: 1049-1056, 2011
16. Lee CP, Zenios SA, Chertow GM: Cost-effectiveness of frequent incenter hemodialysis. J Am Soc Nephrol 19: 1792-1797, 2008
17. Agar JW, Knight RJ, Simmonds RE, Boddington JM, Waldron CM, Somerville CA: Nocturnal haemodialysis: An Australian cost comparison with conventional satellite haemodialysis. Nephrology (Carlton) 10: 557-570, 2005 (Pubitemid 41801835)
18. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C: Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 40: 611-622, 2002 (Pubitemid 34971291)
19. Pauly RP, Gill JS, Rose CL, Asad RA, Chery A, Pierratos A, Chan CT: Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 24: 2915-2919, 2009
20. Komenda P, Gavaghan MB, Garfield SS, Poret AW, Sood MM: An economic assessment model for in-center, conventional home, and more frequent home hemodialysis. Kidney Int 81: 307-313, 2012
21. Clement FM, Klarenbach S, Tonelli M, Wiebe N, Hemmelgarn B, Manns BJ: An economic evaluation of erythropoiesis-stimulating agents in CKD. Am J Kidney Dis 56: 1050-1061, 2010
22. Manns B, Klarenbach S, Lee H, Culleton B, Shrive F, Tonelli M: Economic evaluation of sevelamer in patients with end-stage renal disease. Nephrol Dial Transplant 22: 2867-2878, 2007 (Pubitemid 350093448)
23. Manns B, Hemmelgarn B, Tonelli M, Au F, Chiasson TC, Dong J, Klarenbach S; Alberta Kidney Disease Network: Population based screening for chronic kidney disease: Cost effectiveness study. BMJ 341: c5869, 2010
24. Canadian Agency for Drugs and Technologies in Health: Guidelines for the Economic Evaluation of Health Technologies, 3rd Ed., Ottawa, ON, Canada, Canadian Agency for Drugs and Technologies in Health, 2006
25. Statistics Canada: Consumer Price Index for Canada [Health Care], 2010. Available at: http://www.statcan.gc.ca/pub/62-001-x/62-001-x2010001-eng.htm. Accessed February 1, 2013
26. Manns B, Doig CJ, Lee H, Dean S, TonelliM, Johnson D, Donaldson C: Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery. Crit Care Med 31: 449-455, 2003 (Pubitemid 36232939)
27. Barnieh L, Manns BJ, Klarenbach S, Mclaughlin K, Yilmaz S, Hemmelgarn BR: A description of the costs of living and standard criteria deceased donor kidney transplantation. Am J Transplant 11: 478-488, 2011
28. Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS; Frequent Hemodialysis Network Trial Group: Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol 24: 498-505, 2013
29. Tonelli M, Klarenbach S, Jindal K, Manns B; Alberta Kidney Disease Network: Economic implications of screening strategies in arteriovenous fistulae. Kidney Int 69: 2219-2226, 2006 (Pubitemid 43882109)
30. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl JMed 341: 1725-1730, 1999
31. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242, 1996 (Pubitemid 26323718)
32. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M: Overview of the Alberta Kidney Disease Network. BMC Nephrol 10: 30, 2009